These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 16583210

  • 1. Both Th1 and Th2 chemokines are elevated in sera of patients with autoimmune blistering diseases.
    Echigo T, Hasegawa M, Shimada Y, Inaoki M, Takehara K, Sato S.
    Arch Dermatol Res; 2006 Jun; 298(1):38-45. PubMed ID: 16583210
    [Abstract] [Full Text] [Related]

  • 2. Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis.
    Shimada Y, Takehara K, Sato S.
    J Dermatol Sci; 2004 May; 34(3):201-8. PubMed ID: 15113590
    [Abstract] [Full Text] [Related]

  • 3. Serum levels of a Th1 chemoattractant IP-10 and Th2 chemoattractants, TARC and MDC, are elevated in patients with systemic sclerosis.
    Fujii H, Shimada Y, Hasegawa M, Takehara K, Sato S.
    J Dermatol Sci; 2004 Jun; 35(1):43-51. PubMed ID: 15194146
    [Abstract] [Full Text] [Related]

  • 4. Treatment with IFN-gamma increases serum levels of Th1 chemokines and decreases those of Th2 chemokines in patients with mycosis fungoides.
    Hino R, Shimauchi T, Tokura Y.
    J Dermatol Sci; 2005 Jun; 38(3):189-95. PubMed ID: 15927812
    [Abstract] [Full Text] [Related]

  • 5. Alterations of serum Th1 and Th2 chemokines by combination therapy of interferon-gamma and narrowband UVB in patients with mycosis fungoides.
    Shimauchi T, Sugita K, Nishio D, Isoda H, Abe S, Yamada Y, Hino R, Ogata M, Kabashima K, Tokura Y.
    J Dermatol Sci; 2008 Jun; 50(3):217-25. PubMed ID: 18243665
    [Abstract] [Full Text] [Related]

  • 6. Serum chemokine profile in patients with bullous pemphigoid.
    Nakashima H, Fujimoto M, Asashima N, Watanabe R, Kuwano Y, Yazawa N, Maruyama N, Okochi H, Kumanogoh A, Tamaki K.
    Br J Dermatol; 2007 Mar; 156(3):454-9. PubMed ID: 17300233
    [Abstract] [Full Text] [Related]

  • 7. Serum levels of the Th1 promoter IL-12 and the Th2 chemokine TARC are elevated in erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis and correlate with soluble Fas ligand expression. An immunoenzymatic study from the Italian Group of Immunopathology.
    Quaglino P, Caproni M, Antiga E, Del Bianco E, Osella-Abate S, Savoia P, Frezzolini A, Schena D, Marzano A, Volpi W, De Simone C, Parodi A, Fabbri P, Bernengo MG, Italian Group of Immunopathology.
    Dermatology; 2007 Mar; 214(4):296-304. PubMed ID: 17460400
    [Abstract] [Full Text] [Related]

  • 8. Circulating levels of Th1 and Th2 chemokines in patients with ankylosing spondylitis.
    Wang J, Zhao Q, Wang G, Yang C, Xu Y, Li Y, Yang P.
    Cytokine; 2016 May; 81():10-4. PubMed ID: 26827189
    [Abstract] [Full Text] [Related]

  • 9. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis.
    Jahnz-Rozyk K, Targowski T, Paluchowska E, Owczarek W, Kucharczyk A.
    Allergy; 2005 May; 60(5):685-8. PubMed ID: 15813816
    [Abstract] [Full Text] [Related]

  • 10. Release of both CCR4-active and CXCR3-active chemokines during human allergic pulmonary late-phase reactions.
    Bochner BS, Hudson SA, Xiao HQ, Liu MC.
    J Allergy Clin Immunol; 2003 Nov; 112(5):930-4. PubMed ID: 14610482
    [Abstract] [Full Text] [Related]

  • 11. A role for TARC/CCL17, a CC chemokine, in systemic lupus erythematosus.
    Okamoto H, Koizumi K, Yamanaka H, Saito T, Kamatani N.
    J Rheumatol; 2003 Nov; 30(11):2369-73. PubMed ID: 14677179
    [Abstract] [Full Text] [Related]

  • 12. Increased macrophage-derived chemokine in exhaled breath condensate and plasma from children with asthma.
    Leung TF, Wong GW, Ko FW, Lam CW, Fok TF.
    Clin Exp Allergy; 2004 May; 34(5):786-91. PubMed ID: 15144472
    [Abstract] [Full Text] [Related]

  • 13. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity.
    Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H, Torii H, Asahina A, Onai N, Matsushima K, Tamaki K.
    J Allergy Clin Immunol; 2001 Mar; 107(3):535-41. PubMed ID: 11240957
    [Abstract] [Full Text] [Related]

  • 14. Chemokines in onchocerciasis patients after a single dose of ivermectin.
    Fendt J, Hamm DM, Banla M, Schulz-Key H, Wolf H, Helling-Giese G, Heuschkel C, Soboslay PT.
    Clin Exp Immunol; 2005 Nov; 142(2):318-26. PubMed ID: 16232219
    [Abstract] [Full Text] [Related]

  • 15. Cord blood cytokines and chemokines and development of allergic disease.
    Sandberg M, Frykman A, Ernerudh J, Berg G, Matthiesen L, Ekerfelt C, Nilsson LJ, Jenmalm MC.
    Pediatr Allergy Immunol; 2009 Sep; 20(6):519-27. PubMed ID: 19175890
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Plasma levels of monokine induced by interferon-gamma/chemokine (C-X-X motif) ligand 9, thymus and activation-regulated chemokine/chemokine (C-C motif) ligand 17 in children with Kawasaki disease.
    Feng S, Yadav SK, Gao F, Yi Q.
    BMC Pediatr; 2015 Sep 03; 15():109. PubMed ID: 26337791
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.